PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fewer than 1 in 10 older heart patients get life-saving defibrillators

2015-06-23
(Press-News.org) DURHAM, N.C. - Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association. But fewer than 1 in 10 eligible patients actually get a defibrillator within a year of their heart attacks, the study found.

Advanced age, transitions in care between the hospital and an outpatient clinic, and a mandatory waiting period to get a defibrillator after a heart attack were the most likely factors for low rates of use, according to the study.

Defibrillators shock hearts back to pumping when a patient experiences a potentially fatal sudden cardiac arrest. Prior studies have primarily shown benefits to using these devices in younger patients.

"Defibrillators are life-saving therapies that have a lot of evidence supporting their use," said Tracy Wang, M.D., an associate professor of cardiology at the Duke University School of Medicine and senior author of the study. "But not every older patient wants one. There is a trade-off between the risks and benefits of the device. But current data suggests that we are grossly underutilizing this therapy."

Clinicians and researchers continue to debate the best use of defibrillators in older heart patients. As a result, Duke researchers expected less than 100 percent usage of the devices, but were surprised at just how few of the 10,318 heart attack patients with reduced heart function in the study actually received them.

The patients in this retrospective, observational study were an average of 78 years old, and 44 percent of them were more than 80 years old. Their data were collected by 441 hospitals across the U.S. participating in a National Cardiovascular Data Registry.

Most previous clinical trials on defibrillators, which have been in use since the 1980s, have focused on patients in their 60s, Wang said, so the benefits of defibrillator use in older adults is not well established. More than 300,000 people in the U.S. die from sudden cardiac arrest each year, and previous research indicated that as many as 80 percent of these patients were eligible for but did not have a defibrillator implanted before they suffered the arrest.

"This is a big debate from a quality-of-life perspective," Wang said. "The decision about defibrillators has to be individualized. For older patients who are debilitated, providing a defibrillator could simply extend a low quality of life."

In the Duke-led study, patients who had defibrillators implanted had a one-third lower risk of death after two years than those who didn't have a defibrillator.

The findings of lower death risk are promising, Wang said, although this may be because doctors were more likely to implant defibrillators in older patients who were healthier overall.

Still, "the rates of use across the U.S. are too low," Wang said. "More work needs to be done to understand what the exact target number should be."

While researchers weigh age and the cost of the procedure, which is a reimbursable service under Medicare for many recipients, researchers also considered another potential barrier to their effective use -- a gap in care at a time when patients are most vulnerable.

"The optimal timing for implanting a defibrillator is still in question, but current guidelines recommend that patients wait at least 40 days after their heart attack," said Sean Pokorney, M.D., a cardiology fellow at the Duke University School of Medicine and lead author of the study. "If the patient's heart is still having trouble pumping blood after 40 days, they would be eligible. But a lot can happen in that 40 days."

In most cases, patients will have been discharged from the hospital and transitioned to an outpatient care team, Pokorney said. Patients who stay connected with their cardiologists and continue to attend follow-up appointments are more likely to get the devices. But the patient's regular physician might not be aware of the patient's reduced heart function or might think the patient's advanced age makes them a poor candidate a defibrillator.

"We believe that age alone should not prevent eligible people from getting devices," Pokorney said. "We should be trying to understand how to refine patient selection towards those who are most likely to benefit from the device, and close any system-level gaps that present a barrier to optimal defibrillator use."

The study is limited as a retrospective observation, Pokorney said, and further research is needed to determine evidence-based approaches to defibrillator use in eligible patients, and practices that encourage close patient follow-up and communication.

INFORMATION:

In addition to Wang and Pokorney, who are also affiliated with the Duke Clinical Research Institute, study authors include Amy L. Miller; Anita Y. Chen; Laine Thomas; Gregg C. Fonarow; James A. de Lemos; Sana M. Al-Khatib; and Eric D. Peterson.

The researchers received funding for this study from the Agency for Healthcare Research and Quality (U19HS021092). Both Wang and Pokorney reported receiving research support from Boston Scientific, in addition to other pharmaceutical companies. A full list of disclosures is included in the manuscript.



ELSE PRESS RELEASES FROM THIS DATE:

Implantable cardioverter-defibrillators underused among older patients after heart attack

2015-06-23
Among Medicare patients who experienced a heart attack from 2007 to 2010, fewer than 1 in 10 eligible patients with low ejection fraction (a measure of how well the left ventricle of the heart pumps blood with each beat) received an implantable cardioverter-defibrillator (ICD) within 1 year after the heart attack, even though ICD implantation was associated with a lower risk of death at 2 years after implantation, according to a study in the June 23/30 issue of JAMA. More than 350,000 people experience sudden cardiac death in the United States annually. Clinical trials ...

Drug used in ED medications associated with small increased risk of malignant melanoma

2015-06-23
Among men in Sweden, use of erectile dysfunctions drugs with phosphodiesterase type 5 inhibitors was associated with a modest but significant increased risk of malignant melanoma, although the pattern of association raises questions about whether this association is causal, according to a study in the June 23/30 issue of JAMA. Phosphodiesterase type 5 (PDE5; an enzyme), the target of oral erectile dysfunction (ED) drugs, is part of a pathway that has been implicated in the development of malignant melanoma. This has raised questions whether PDE5 inhibitors used to treat ...

Benefit of early screening for vascular disorder among extremely preterm infants

2015-06-23
Among extremely preterm infants, early screening for the vascular disorder patent ductus arteriosus before day 3 of life was associated with a lower risk of in-hospital death and pulmonary hemorrhage, but not with differences in other severe complications, according to a study in the June 23/30 issue of JAMA. The ductus arteriosus is a blood vessel in a fetus that bypasses pulmonary circulation by connecting the pulmonary artery directly to the ascending aorta. It usually closes within 72 hours of birth in most normal-term infants. However, failure to close is common ...

Mixed findings regarding quality of evidence supporting benefit of medical marijuana

2015-06-23
In an analysis of the findings of nearly 80 randomized trials that included about 6,500 participants, there was moderate-quality evidence to support the use of cannabinoids (chemical compounds that are the active principles in cannabis or marijuana) for the treatment of chronic pain and lower-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, sleep disorders, and Tourette syndrome, according to a study in the June 23/30 issue of JAMA. Medical cannabis refers to the use of cannabis or cannabinoids ...

Study finds inaccuracy in dosing of edible medical marijuana products

2015-06-23
An analysis of edible medical marijuana products from 3 major metropolitan areas found that many had lower amounts of key substances than labeled, which may not produce the desired medical benefit, while others contained significantly more of a certain substance than labeled, placing patients at risk of experiencing adverse effects, according to a study in the June 23/30 issue of JAMA. As the use of cannabis (marijuana) for medical purposes has expanded, a variety of edible products for oral consumption has been developed. An estimated 16 percent to 26 percent of patients ...

Medical marijuana 'edibles' mostly mislabeled, study shows

2015-06-23
In a proof-of-concept study, a team led by a Johns Hopkins researcher reports that the vast majority of edible cannabis products sold in a small sample of medical marijuana dispensaries carried labels that overstated or understated the amount of delta-9-tetrahydrocannabinol (THC). Though the scope of the study was small, the researchers say, the results of the study suggest some medical cannabis patients could be unintentionally overdosing or are being cheated by mislabeled products. "If this study is representative of the medical cannabis market, we may have hundreds ...

Dietary guidelines for Americans shouldn't place limits on total fat intake

2015-06-23
BOSTON, June 23 -- In a Viewpoint published today in the Journal of the Medical Association (JAMA), researchers from the Friedman School of Nutrition Science and Policy at Tufts University and Boston Children's Hospital call on the federal government to drop restrictions on total fat consumption in the forthcoming 2015 Dietary Guidelines for Americans. Co-authors Dariush Mozaffarian, M.D., Dr.P.H., dean of the Friedman School, and David Ludwig, M.D., Ph.D., director of the New Balance Foundation Obesity Prevention Center at Boston Children's Hospital, highlight a key, ...

Old-school literature search helps ecologist identify puzzling parasite

2015-06-23
ANN ARBOR--A months-long literature search that involved tracking down century-old scientific papers and translating others from Czech and French helped University of Michigan ecologist Meghan Duffy answer a question she'd wondered about for years. The early studies helped Duffy determine that the microscopic aquatic parasite she first observed as a graduate student, and which her research team had recently collected in more than a dozen southeast Michigan lakes, is the same fungus-like organism that a French biologist first described in 1903. "The longer historical ...

National identity: Does buying local mean shunning global?

2015-06-23
U.S. consumers are often urged to "buy American," and some special interest groups even claim that buying foreign products is inappropriate, or even immoral. But when it comes to buying domestic products, positive feelings for one's own country may play a more important role than negative feelings toward another, according to a new study in the Journal of International Marketing. "National identity--feeling proud to be, say, an American--and believing that Americans should not buy foreign products influence attitudes toward domestic products, but the impact of national ...

Patient-initiated workplace violence affects counselors, treatment and outcomes, research finds

2015-06-23
More than four out of five counselors who treat patients for substance abuse have experienced some form of patient-initiated workplace violence according to the first national study to examine the issue, led by Georgia State University Professor Brian E. Bride. The study, forthcoming in the Journal of Substance Abuse Treatment, is the first to measure the extent of workplace violence in substance abuse treatment centers across the United States. Bride and his co-authors analyzed a large, national sample of Substance Use Disorder counselors from the National Institutes ...

LAST 30 PRESS RELEASES:

Launch of the most comprehensive, and up to date European Wetland Map

Lurie Children’s campaign urges parents to follow up right away if newborn screening results are abnormal

Does drinking alcohol really take away the blues? It's not what you think

Speed of risk perception is connected to how information is arranged

High-risk pregnancy specialists analyze AI system to detect heart defects on fetal ultrasound exams

‘Altar tent’ discovery puts Islamic art at the heart of medieval Christianity

Policy briefs present approach for understanding prison violence

Early adult mortality is higher than expected in US post-COVID

Recycling lithium-ion batteries cuts emissions and strengthens supply chain

Study offers new hope for relieving chronic pain in dialysis patients

How does the atmosphere affect ocean weather?

Robots get smarter to work in sewers

Speech Accessibility Project data leads to recognition improvements on Microsoft Azure

Tigers in the neighborhood: How India makes room for both tigers and people

Grove School’s Arthur Paul Pedersen publishes critical essay on scientific measurement literacy

Moffitt study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer

Improving blood transfusion monitoring in critical care patients: Insights from diffuse optics

Powerful legal and financial services enable kleptocracy, research shows

Carbon capture from constructed wetlands declines as they age

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Life cycles of some insects adapt well to a changing climate. Others, not so much.

With generative AI, MIT chemists quickly calculate 3D genomic structures

The gut-brain connection in Alzheimer’s unveiled with X-rays

NIH-funded clinical trial will evaluate new dengue therapeutic

Sound is a primary issue in the lives of skateboarders, study shows

Watch what you eat: NFL game advertisements promote foods high in fat, sodium

Red Dress Collection Concert hosted by Sharon Stone kicks off American Heart Month

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

New Case Western Reserve University study identifies key protein’s role in psoriasis

[Press-News.org] Fewer than 1 in 10 older heart patients get life-saving defibrillators